Blogs about: Living With Prostate Cancer

Featured Blog

BRCA1/2, prostate cancer, and the Angelina Jolie effect2 comments

Sitemaster wrote 1 day ago: According to an article in The Sunday Times in the UK over the weekend, a well-known surgeon in the … more →

Tags: Diagnosis, Management, Treatment, BRCA1, BRCA2, Prophylactic, Risk, Surgery, Treatment

First-line enzalutamide in high-risk, ADT-naive patients (including those with metastatic disease)2 comments

Sitemaster wrote 4 days ago: According to data to be presented at the upcoming meeting of the American Society of Clinical Oncolo … more →

Tags: Drugs in development, Management, Treatment, High Risk, ADT, enzalutamide, First Line, outcome, PSA

Olaparib shows activity in advanced, BRCA1/2-positive prostate cancer2 comments

Sitemaster wrote 5 days ago: Apparently a drug known as olaparib (a so-called poly-ADP ribose polymerase or PARP inhibitor) has s … more →

Tags: Drugs in development, Management, Treatment, activity, BRCA1, BRCA2, olaparib

Tokai gets funding to expand Phase II trial of galeterone in CRPC

Sitemaster wrote 5 days ago: In April 2012 we had noted that Tokai Pharmaceuticals was planning to initiate a Phase II trial of i … more →

Tags: Drugs in development, Management, Treatment, castration-resistant, CRPC, galeterone, TOK-001, trial

US FDA approves radium-223 dichloride for treatment of men with mCRPC

Sitemaster wrote 5 days ago: The “New” Prostate Cancer InfoLink apologizes for a delay in letting readers know that o … more →

Tags: Management, Treatment, castration-resistant, mCRPC, metastatic, Radium-223, Xofigo

Radiation therapy for localized prostate cancer in men with diabetes mellitus

Sitemaster wrote 1 week ago: A new paper recently published on line in Urology (“the Gold Journal”) suggests that men … more →

Tags: Diagnosis, Management, Risk, Treatment, diabetes, external beam, Localized, Radiation

Oncotype DX and risk for clinically significant prostate cancer3 comments

Sitemaster wrote 1 week ago: Last September we asked whether the Oncotype DX test for risk of prostate cancer developed by Genomi … more →

Tags: Diagnosis, Management, Risk, DX, oncotype, Risk, Significant

Ipilimumab ± radiation therapy in men with mCRPC

Sitemaster wrote 1 week ago: Final data have just been reported on the results of a Phase I/II study of treatment with ipilimumab … more →

Tags: Drugs in development, Management, Treatment, castration-resistant, ipilimumab, mCRPC, metastatic

AUA, ASTRO issue new guidance on radiation after radical prostatectomy4 comments

Sitemaster wrote 1 week ago: So the American Urology Association (AUA) is clearly “on a roll” when it comes to guidan … more →

Tags: Management, Treatment, Adjuvant, guideline, RADIATION THERAPY, radical prostatectomy, salvage

AUA also issues new guidance on treatment of patients with CRPC1 comment

Sitemaster wrote 2 weeks ago: Earlier today, the American Urological Association issued new guidance to its members on the managem … more →

Tags: Drugs in development, Management, Treatment, castration-resistant, CRPC, drug, metastatic, non-metastatic, Sequencing

Abiraterone acetate for men with metastatic disease and a sub-optimal response to ADT

Sitemaster wrote 2 weeks ago: The Southwest Oncology Group (SWOG) is very keen to complete the accrual of patients to a small, Pha … more →

Tags: Drugs in development, Management, Treatment, abiraterone, ADT, androgen, Deprivation, Response, sub-optimal

Statin use before diagnosis associated with less risk of prostate cancer-specific mortality2 comments

Sitemaster wrote 2 weeks ago: According to an article just published on line in Prostate, taking statins before a diagnosis of pro … more →

Tags: Diagnosis, Management, Risk, Treatment, Mortality, Risk, statin

New Phase III trial is testing ADT + bicalutamide vs. ADT + TAK-7009 comments

Sitemaster wrote 2 weeks ago: It has been brought to our attention that the Southwest Oncology Group (SWOG) has initiated a new, r … more →

Tags: Drugs in development, Management, Treatment, ADT, androgen deprivation, hormone sensitive, metastatic, orteronel, TAK-700

"HG-PIN alone should not be an indication for further biopsies" in the PSA era

Sitemaster wrote 2 weeks ago: A podium presentation by Kingman et al. at the upcoming annual meeting of the American Urological As … more →

Tags: Diagnosis, Management, Risk, Treatment, biopsy, HG-PIN, high grade, neoplasia, PSA

Patient satisfaction during and after the decision to undergo radical prostatectomy for localized prostate cancer5 comments

Sitemaster wrote 2 weeks ago: A paper to be presented at the upcoming AUA annual meeting from what appears to be an ex-US group of … more →

Tags: Diagnosis, Management, Risk, Treatment, Decision Making, experience?, outcome, radical prostatectomy, Satisfaction

Ablatherm HIFU data on 5,000+ patients with T1 to T3 localized prostate cancer1 comment

Sitemaster wrote 2 weeks ago: Another paper to be presented at the upcoming annual meeting of the American Urological Association … more →

Tags: Diagnosis, Management, Risk, Treatment, Ablatherm, Focused, HIFU, high intensity, outcome

mpMRI in diagnosis and management of prostate cancer tomorrow1 comment

Sitemaster wrote 3 weeks ago: A new review article in Oncology discusses the potential of multiparametric magnetic resonance imagi … more →

Tags: Diagnosis, Management, Risk, imaging, MRI, MultiParametric, prognosis

New meta-analysis endorses IADT for good responders to initial CADT9 comments

Sitemaster wrote 3 weeks ago: A new meta-analysis of data from nine large clinical trials suggests that, “There is fair evid … more →

Tags: Management, Treatment, ADT, androgen, cadt, Continuous, Deprivation, IADT, Intermittent

TMRPSS2-ERG and PCA3 as markers of risk for men entering active surveillance protocols

Sitemaster wrote 3 weeks ago: A new study just published on line in Clinical Cancer Research shows a degree of correlation between … more →

Tags: Diagnosis, Management, Risk, acgtive surveillance, biomarker, PCA3, Risk, TMRPSS2-ERG


Related Tags
All →

Follow this tag via RSS